Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
BlackBerry
BB
$5.22B
| $5.96M | 0.01% |
+1,219,284
| New | +$5.51M |
|
1527
TransUnion
TRU
$15.4B
| $5.96M | 0.01% |
68,500
-242,500
| -78% | -$19.4M |
|
1528
Civeo
CVEO
$344M
| $5.94M | 0.01% |
803,204
-54,705
| -6% | -$337K |
|
1529
Rafael Holdings
RFL
$103M
| $5.94M | 0.01% |
418,833
-24,843
| -6% | -$342K |
|
1530
United Natural Foods
UNFI
$2.93B
| $5.93M | 0.01% |
325,650
+274,738
| +540% | +$4.12M |
|
1531
StealthGas
GASS
$352M
| $5.93M | 0.01% |
2,156,054
-5,100
| -0.2% | -$12.5K |
|
1532
PagSeguro Digital
PAGS
$2.4B
| $5.93M | 0.01% |
+167,745
| New | +$4.72M |
|
1533
Editas Medicine
EDIT
$433M
| $5.92M | 0.01% |
200,100
-100,800
| -33% | -$2.63M |
|
1534
Avient
AVNT
$4.25B
| $5.92M | 0.01% |
225,558
+85,700
| +61% | +$1.99M |
|
1535
Titan Machinery
TITN
$429M
| $5.9M | 0.01% |
543,500
+142,700
| +36% | +$1.36M |
|
1536
Graham Corp
GHM
$1.34B
| $5.89M | 0.01% |
462,596
+3,800
| +0.8% | +$46.4K |
|
1537
Meritage Homes
MTH
$4.76B
| $5.88M | 0.01% |
154,400
+64,800
| +72% | +$1.91M |
|
|
MIXT
1538
DELISTED
MIX TELEMATICS LIMITED
MIXT
| $5.87M | 0.01% |
680,400
+76,700
| +13% | +$676K |
|
1539
SPX Corp
SPXC
$10.9B
| $5.86M | 0.01% |
142,400
-16,700
| -10% | -$629K |
|
1540
Santander
BSBR
$43.2B
| $5.85M | 0.01% |
1,169,176
-996,184
| -46% | -$4.81M |
|
|
AMBR
1541
Amber International Holding Ltd
AMBR
$124M
| $5.84M | 0.01% |
109,534
+84,236
| +333% | +$4.16M |
|
1542
Zumiez
ZUMZ
$314M
| $5.83M | 0.01% |
213,000
-20,100
| -9% | -$457K |
|
1543
ARK Web x.0 ETF
ARKW
$1.8B
| $5.82M | 0.01% |
68,600
+40,342
| +143% | +$2.83M |
|
1544
Capital City Bank Group
CCBG
$898M
| $5.82M | 0.01% |
277,691
-2,700
| -1% | -$53K |
|
1545
Schwab US TIPS ETF
SCHP
$16.2B
| $5.82M | 0.01% |
+193,800
| New | +$5.74M |
|
1546
Trade Desk
TTD
$6.64B
| $5.81M | 0.01% |
143,000
-1,678,580
| -92% | -$50.6M |
|
1547
Crawford & Co Class B
CRD.B
$593M
| $5.8M | 0.01% |
825,417
+5,700
| +0.7% | +$36.1K |
|
|
XHR
1548
Xenia Hotels & Resorts
XHR
$1.77B
| $5.8M | 0.01% |
621,300
+523,498
| +535% | +$4.88M |
|
|
CORE
1549
DELISTED
Core Mark Holding Co., Inc.
CORE
| $5.75M | 0.01% |
230,400
+143,700
| +166% | +$3.85M |
|
1550
InfuSystem Holdings
INFU
$244M
| $5.75M | 0.01% |
497,909
+18,901
| +4% | +$217K |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.